Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BIDE PHARMATECH CO., LTD. |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 61.46 CNY | -1.32% | -2.26% | +4.74% | |
| Sales 2023 * | 1,131 M 158 M | Sales 2024 * | 1,518 M 212 M | Capitalization | 5,660 M 792 M |
|---|---|---|---|---|---|
| Net income 2023 * | 191 M 26.74 M | Net income 2024 * | 257 M 35.98 M | EV / Sales 2023 * | 5,00x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3,73x |
| P/E ratio 2023 * | 29,6x | P/E ratio 2024 * | 22,0x | Employees | 617 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 32.37% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.32% | ||
| 1 week | -2.26% | ||
| Current month | -1.32% | ||
| 1 month | -6.37% | ||
| 3 months | -16.83% | ||
| 6 months | -18.50% | ||
| Current year | +4.74% |
1 week
59.56
63.48
1 month
59.5669.62
Current year
57.13114.05
1 year
54.64114.05
3 years
44.64114.05
5 years
44.64114.05
10 years
44.64114.05
| Managers | Title | Age | Since |
|---|---|---|---|
Shi Zhuangzhi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-30 | 61.46 | -1.32% | 794 602 |
| 23-11-30 | 62.28 | -0.05% | 762,686 |
| 23-11-29 | 62.31 | -0.50% | 910,024 |
| 23-11-28 | 62.62 | +1.20% | 925,798 |
| 23-11-27 | 61.88 | +1.21% | 980,455 |
End-of-day quote Shanghai Stock Exchange, December 30, 2023
More quotes
Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
61.46CNY
Average target price
103.00CNY
Spread / Average Target
+67.59%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.74% | 793 M $ | |
| +66.03% | 40 225 M $ | |
| +4.46% | 39 073 M $ | |
| -57.25% | 29 626 M $ | |
| -26.02% | 28 824 M $ | |
| +36.96% | 21 976 M $ | |
| -29.46% | 21 114 M $ | |
| +1.62% | 17 420 M $ | |
| -13.92% | 11 278 M $ | |
| -9.57% | 10 110 M $ |
